Patient Leaflet Updated 16-Sep-2025 | MSN Laboratories Europe Ltd
Azacitidine film-coated tablets
Azacitidine 200 mg film-coated tablets
Azacitidine 300 mg film-coated tablets
azacitidine
1. What Azacitidine is and what it is used for
2. What you need to know before you take Azacitidine
3. How to take Azacitidine
4. Possible side effects
5. How to store Azacitidine
6. Contents of the pack and other information
Azacitidine is an anti-cancer medicine that belongs to a group of medicines called anti- metabolites. Azacitidine contains the active substance azacitidine.
Azacitidine is used to treat adults with acute myeloid leukaemia (AML). This is a form of cancer which affects your bone marrow and can cause problems with producing normal blood cells.
Azacitidine is used to keep the disease in control (remission, when the disease is less severe or not active).
Azacitidine works by preventing cancer cells from growing. azacitidine, the active substance in azacitidine, works by altering the way the cell turns genes on and off. It also reduces the production of new genetic material (RNA and DNA). These effects are thought to block growth of cancer cells in leukaemia.
Talk to your doctor or nurse if you have any questions about how azacitidine works or why this medicine has been prescribed for you.
Blood tests
You will have blood tests before you begin treatment with azacitidine and during treatment with azacitidine to check that you have enough blood cells and that your liver and kidneys are working properly. Your doctor will decide how often you have blood tests.
Tell your doctor, pharmacist or nurse straight away if you get any of these symptoms during treatment with azacitidine:
Your doctor may need to change the dose, interrupt treatment or stop treatment with azacitidine completely. The doctor may prescribe other medicines to help manage these symptoms.
Azacitidine is not recommended for use in children and adolescents below the age of 18.
Tell your doctor if you are taking, have recently taken or might take any other medicines. This is because azacitidine may affect the way some other medicines work. Also, some other medicines may affect the way azacitidine works.
If you are pregnant or breast-feeding, you think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. Men should not father a child while receiving treatment with azacitidine.
Pregnancy
Do not take azacitidine during pregnancy as it may be harmful to your baby. Tell your doctor straight away if you become pregnant during treatment.
Contraception
If you are a woman who can become pregnant you should use an effective method of contraception while taking azacitidine and for 6 months after stopping treatment with azacitidine. Men should use an effective method of contraception while taking azacitidine and for 3 months after stopping treatment with azacitidine.
Your doctor will discuss with you the most suitable method of contraception for you to use.
Breast-feeding
Do not breast-feed while taking azacitidine as it may be harmful to your child.
Azacitidine may affect your ability to have a baby. Talk to your doctor for advice before using it.
You may feel tired, weak or have trouble concentrating. If this happens to you or if you have other side effects, do not drive or use any machines or tools.
This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.
Always take this medicine exactly as your doctor has told you. Check with your doctor if you are not sure.
Azacitidine is given in treatment cycles of 28 days.
Your doctor will tell you what dose of azacitidine to take. The doctor may decide to:
Always take azacitidine as prescribed by your doctor.
Your doctor will give you a medicine that helps to reduce nausea (feeling sick) and vomiting. You take it 30 minutes before each azacitidine tablet, during your first and second treatment cycles. Your doctor will tell you to take it for a longer period, if you need it.
If you vomit after taking a tablet, do not take another dose on the same day. Instead, wait till the next day and take your next scheduled dose then. Do not take two doses on the same day.
If powder from a broken tablet touches your skin, wash the skin straight away and thoroughly with soap and water. If the powder gets into your eyes, nose or mouth, flush the area thoroughly with water.
If you take more tablets than you should, contact your doctor or go to a hospital straightaway. If possible, take the medicine pack and this leaflet with you.
If you forget to take azacitidine at the usual time, take your usual dose as soon as you remember on the same day and take your next dose at the usual time the next day. Do not take a double dose to make up for a forgotten or vomited tablet.
Do not stop taking azacitidine unless your doctor tells you to.
If you have any further questions on the use of this medicine, ask your doctor.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Tell your doctor, pharmacist or nurse straight away if you get any of these symptoms during treatment with azacitidine:
Very common side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at http://www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and the carton after EXP. The expiry date refers to the last day of that month.
Store below 30°C.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is azacitidine.
Each film-coated tablet contains 200 mg azacitidine.
Each film-coated tablet contains 300 mg azacitidine.
The other ingredients are:
Tablet core: Silicified microcrystalline cellulose, mannitol, croscarmellose sodium and magnesium stearate.
Tablet film coating:
[200 mg]: Polyethylene glycol – 8000, opadry pink containing: hypromellose (E464), titanium dioxide (E171), macrogol (E1521), triacetin and iron oxide red (E172).
[300 mg]: Polyethylene glycol – 8000, opadry brown containing: hypromellose (E464), titanium dioxide (E171), macrogol (E1521), triacetin, iron oxide yellow (E172), iron oxide red (E172) and iron oxide black (E172).
Azacitidine 200 mg film-coated tablets are pink coloured, oval shaped, biconvex, film-coated tablets debossed with “MA” on one side and “24” on the other side.
Azacitidine 300 mg film-coated tablets are brown coloured, oval shaped, biconvex, film-coated tablets debossed with “MA” on one side and “25” on the other side.
The film-coated tablets are packaged in blisters.
Each pack contains either 7 or 14 film-coated tablets.
Not all pack sizes may be marketed.
The leaflet was last approved in June 2024.
Devonshire, Business Centre, Works road, Letchworth Garden City, Herts, SG6 1GJ, UK
020 3371 7158
07789 669 333
www.msnlabs.com
020 3371 7158
07831 268 255